Clinical Trial Feasibility
Determining Feasibility - A Simple Question but a Complicated Process.
One of the overarching aims of PACT is to implement resources to maximise local PF clinical trial activity and capacity.
Determining clinical trial feasibility is an essential site assessment process and involves asking the question – if a clinical trial is run at a particular site, will it be successful? Answering that question, however, is a complicated and time-consuming process.
Sponsors need to investigate and identify trial sites that have the participants, staff, expertise and technology to successfully conduct their study.
Trial sites need to understand what sponsors are looking for, as well as evaluate their own resources to decide whether a trial is a good match for their site.
The clinical trial feasibility process is time-consuming, expensive and vital.
The PACT Australasian PF Clinical Trial Site Capability Register is a platform that streamlines this process and will save sponsors and trial sites time by reducing the completion and collection of endless paperwork by eliminating the need to contact sites directly at the initial assessment stage.
What is the Australasian PF Clinical Trial Site Capability Register?
The aim of the Capability Register is to guide trial site contact so that it is more targeted, with sponsors and CROs only offering participation to sites with capabilities relevant to their planned trial.
Additionally, the capability register will enable a broader range of trial sites to be visible to sponsors and CROs, bringing trial participation to sites and regions beyond the traditional expert centres, thus helping to improve equity of access.
If you are a clinical trial site located in Australia or New Zealand, and you are interested in being involved, please contact the PACT Project Manager, Jennifer Walsh via jennifer.walsh@sydney.edu.au.